| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 159 |
| 1 | FLUOROURACIL | 77 |
| 2 | FLUOROURACIL CREAM, 0.5% | 77 |
| 3 | CAPECITABINE | 57 |
| 4 | TACROLIMUS | 53 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 53 |
| 6 | TACROLIMUS OINTMENT 0.1% | 53 |
| 7 | AZATHIOPRINE | 40 |
| 8 | MYCOPHENOLATE MOFETIL | 26 |
| 9 | LEUCOVORIN CALCIUM | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXALIPLATIN | 159 | 0.0021 |
| 1 | ADO-TRASTUZUMAB EMTANSINE | 13 | 0.0015 |
| 2 | EFAVIRENZ | 12 | 0.0011 |
| 3 | LEUCOVORIN CALCIUM | 21 | 0.0011 |
| 4 | FLUOROURACIL CREAM, 0.5% | 77 | 0.0010 |
| 5 | FLUOROURACIL | 77 | 0.0010 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 8 | 0.0009 |
| 7 | GINKGO BILOBA | 1 | 0.0007 |
| 8 | CAPECITABINE | 57 | 0.0006 |
| 9 | ALBUMIN HUMAN | 3 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Platinum-based Drug [EPC] | 161 | 0.0006 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 12 | 0.0005 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 132 | 0.0005 |
| 3 | Actinomycin [EPC] | 1 | 0.0005 |
| 4 | Purine Antimetabolite [EPC] | 40 | 0.0004 |
| 5 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 14 | 0.0003 |
| 7 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 8 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |